Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart Association
Laxmi S. Mehta, Karol E. Watson, Ana Barac, et al.
Circulation (2018) Vol. 137, Iss. 8
Open Access | Times Cited: 668

Showing 1-25 of 668 citing articles:

Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations
Giuseppe Curigliano, Daniel J. Lenihan, Michael G. Fradley, et al.
Annals of Oncology (2020) Vol. 31, Iss. 2, pp. 171-190
Open Access | Times Cited: 804
Sex differences in heart failure
Carolyn S.P. Lam, Clare Arnott, A. Beale, et al.
European Heart Journal (2019) Vol. 40, Iss. 47, pp. 3859-3868c
Open Access | Times Cited: 575
Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases
Helen Strongman, Sarah Gadd, Anthony Matthews, et al.
The Lancet (2019) Vol. 394, Iss. 10203, pp. 1041-1054
Open Access | Times Cited: 388
Human cardiac organoids for the modelling of myocardial infarction and drug cardiotoxicity
Dylan Richards, Yang Li, Charles M. Kerr, et al.
Nature Biomedical Engineering (2020) Vol. 4, Iss. 4, pp. 446-462
Open Access | Times Cited: 328
Cardiotoxicity of Anthracyclines
Daniela Cardinale, Iacopo Fabiani, Carlo M. Cipolla
Frontiers in Cardiovascular Medicine (2020) Vol. 7
Open Access | Times Cited: 323
Obesity and Cancer: A Current Overview of Epidemiology, Pathogenesis, Outcomes, and Management
Sukanya Pati, Wadeed Irfan, Ahmed Tariq Jameel, et al.
Cancers (2023) Vol. 15, Iss. 2, pp. 485-485
Open Access | Times Cited: 318
Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio‐Oncology Council of the European Society of Cardiology (ESC)
Jelena Čelutkienė, Radek Pudil, Teresa López‐Fernández, et al.
European Journal of Heart Failure (2020) Vol. 22, Iss. 9, pp. 1504-1524
Open Access | Times Cited: 306
Classification, prevalence, and outcomes of anticancer therapy-induced cardiotoxicity: the CARDIOTOX registry
José López‐Sendón, Carlos Álvarez-Ortega, Pilar Auñón, et al.
European Heart Journal (2020) Vol. 41, Iss. 18, pp. 1720-1729
Open Access | Times Cited: 211
Cardio-oncology - strategies for management of cancer-therapy related cardiovascular disease
Matthias Totzeck, Martin Schüler, Martin Stuschke, et al.
International Journal of Cardiology (2019) Vol. 280, pp. 163-175
Closed Access | Times Cited: 183
Fatal heart disease among cancer patients
Kelsey C. Stoltzfus, Ying Zhang, Kathleen M. Sturgeon, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 179
Heart toxicity from breast cancer radiotherapy
Marc D. Piroth, René Baumann, Wilfried Budach, et al.
Strahlentherapie und Onkologie (2018) Vol. 195, Iss. 1, pp. 1-12
Open Access | Times Cited: 178
Adverse effects of tyrosine kinase inhibitors in cancer therapy: pathophysiology, mechanisms and clinical management
Sunitha Shyam Sunder, Umesh C. Sharma, Saraswati Pokharel
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 174
Ten things to know about ten cardiovascular disease risk factors
Harold Bays, Pam R. Taub, Elizabeth Epstein, et al.
American Journal of Preventive Cardiology (2021) Vol. 5, pp. 100149-100149
Open Access | Times Cited: 169
Cardio-Oncology: Vascular and Metabolic Perspectives: A Scientific Statement From the American Heart Association
Umberto Campia, Javid J. Moslehi, Laleh Amiri‐Kordestani, et al.
Circulation (2019) Vol. 139, Iss. 13
Open Access | Times Cited: 168
A Mendelian randomization study of the effects of blood lipids on breast cancer risk
Christoph Nowak, Johan Ärnlöv
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 161
Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors
Neha Bansal, M. Jacob Adams, Sarju Ganatra, et al.
Cardio-Oncology (2019) Vol. 5, Iss. 1
Open Access | Times Cited: 159
JCS/JACR 2021 Guideline on Rehabilitation in Patients With Cardiovascular Disease
Shigeru Makita, Takanori Yasu, Yoshihiro J. Akashi, et al.
Circulation Journal (2022) Vol. 87, Iss. 1, pp. 155-235
Open Access | Times Cited: 143
Physical Activity Before, During, and After Chemotherapy for High-Risk Breast Cancer: Relationships With Survival
Rikki A. Cannioto, Alan D. Hutson, Shruti Dighe, et al.
JNCI Journal of the National Cancer Institute (2020) Vol. 113, Iss. 1, pp. 54-63
Open Access | Times Cited: 140
Cooperative sensing of mitochondrial DNA by ZBP1 and cGAS promotes cardiotoxicity
Yuanjiu Lei, Jordyn J. VanPortfliet, Yifan Chen, et al.
Cell (2023) Vol. 186, Iss. 14, pp. 3013-3032.e22
Open Access | Times Cited: 114
Incident Cardiovascular Disease Among Adults With Cancer
D. Ian Paterson, Natasha Wiebe, Winson Y. Cheung, et al.
JACC CardioOncology (2022) Vol. 4, Iss. 1, pp. 85-94
Open Access | Times Cited: 113
Ten things to know about ten cardiovascular disease risk factors – 2022
Harold Bays, Anandita Agarwala, Charles German, et al.
American Journal of Preventive Cardiology (2022) Vol. 10, pp. 100342-100342
Open Access | Times Cited: 79
A drug-free cardiovascular stent functionalized with tailored collagen supports in-situ healing of vascular tissues
Haoshuang Wu, Li Yang, Rifang Luo, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 24
Heart failure pharmacotherapy and cancer: pathways and pre-clinical/clinical evidence
Nabil V. Sayour, Á. Paál, Pietro Ameri, et al.
European Heart Journal (2024) Vol. 45, Iss. 14, pp. 1224-1240
Open Access | Times Cited: 18
Linking Heart Failure to Cancer
Edoardo Bertero, Marco Canepa, Christoph Maack, et al.
Circulation (2018) Vol. 138, Iss. 7, pp. 735-742
Open Access | Times Cited: 147
Anthracycline‑induced cardiotoxicity in the chemotherapy treatment of breast cancer: Preventive strategies and treatment (Review)
Fengfeng Cai, Manuel A. Luis, Xiaoyan Lin, et al.
Molecular and Clinical Oncology (2019)
Open Access | Times Cited: 126
Page 1 - Next Page

Scroll to top